The identification of TMEM16F as a PLS required for PS externalization in platelets (19, 20) and the finding that mutations in TMEM16F underlie the mild-to-moderate bleeding disorder Scott syndrome (19, 21) led to further investigation of TMEM16F in platelet function. This evidence concerns the gene ANO6 and hemorrhagic disease.